id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-277803-7p1qu2rf	Rubino, Francesco	Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery	2020-05-07		.txt	text/plain	6092	193	25	National diabetes statistics report 2020: estimates of diabetes and its burden in the United States Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD) Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study Years of life lost due to obesity Morbidity and mortality associated with obesity Prevalence and ethnicity of sleep-disordered breathing and obesity in children Adiposity in relation to age as predictor of severity of sleep apnea in children with snoring Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2 Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response meta-analysos of prospective studies Emerging concepts in the medical and surgical treatment of obesity Using the Edmonton Obesity Staging System to predict mortality in a population-representative cohort of people with overweight and obesity Edmonton Obesity Staging System: association with weight history and mortality risk Non-alcoholic fatty liver disease Practical approach to non-alcoholic fatty liver disease in patients with diabetes Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis NAFLD and diabetes mellitus Nonalcoholic fatty liver disease: a systematic review The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe Bariatric surgery versus intensive medical therapy for diabetes-5-year outcomes Microvascular outcomes in patients with diabetes after bariatric surgery versus usual care: a matched cohort study Bariatric surgery for non-alcoholic steatohepatitis in obese patients Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients Lifestyle intervention and medical management with vs without Roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the Diabetes Surgery Study Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial Clinical and patient-centered outcomes in obese patients with type 2 diabetes 3 years after randomization to Rouxen-Y gastric bypass surgery versus intensive lifestyle management: the SLIMM-T2D study Survival among high-risk patients after bariatric surgery A simple prediction rule for all-cause mortality in a cohort eligible for bariatric surgery Long-term mortality after gastric bypass surgery Long-term mortality rates (>8-year) improve as compared to the general and obese population following bariatric surgery Survival and changes in comorbidities after bariatric surgery Predictors of long-term mortality after bariatric surgery performed in Veterans Affairs medical centers Cancer risk following bariatric surgery-systematic review and meta-analysis of national population-based cohort studies Bariatric surgery and the risk of cancer in a large multisite cohort Bariatric surgery is associated with reduced risk of breast cancer in both premenopausal and postmenopausal women Bariatric surgery is associated with a lower rate of death after myocardial infarction and stroke: a nationwide study Success (but unfinished) story of metabolic surgery Metabolic surgery for the treatment of type 2 diabetes in obese individuals Clinical outcomes of metabolic surgery: efficacy of glycemic control, weight loss, and remission of diabetes Cost-effectiveness of bariatric surgery for severely obese adults with diabetes Preoperative Prediction of type 2 diabetes remission after gastric bypass surgery: a comparison of DiaRem scores and ABCD scores Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study Validating risk prediction models of diabetes remission after sleeve gastrectomy Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese Subjects (SOS) study Health care use during 20 years following bariatric surgery Impact of bariatric surgery on health care costs of obese persons: a 6-year follow-up of surgical and comparison cohorts using health plan data The business case for bariatric surgery revisited: a non-randomized case-control study Long-term expenditures associated with bariatric surgery in VA Association between bariatric surgery and long-term health care expenditures among veterans with severe obesity Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2020 Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials Consensus recommendations for the management of diabetes in patients with COVID-19 Diets with high or low protein content and glycemic index for weight-loss maintenance Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/ topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial Joint international consensus statement for ending stigma of obesity Bariatric, metabolic, and diabetes surgery: what's in a name? Related factors of quality of life of type 2 diabetes patients: a systematic review and meta-analysis Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus Bariatric surgery has been used for decades to treat patients with severe obesity.	cache/cord-277803-7p1qu2rf.txt	txt/cord-277803-7p1qu2rf.txt
